CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status. - Gudmundsdottir,K.; Thorlacius,S.; Jonasson,J.G.; Sigfusson,B.F.; Tryggvadottir,L.; Eyfjord,J.E. (Br J Cancer, 2003)